EF Hutton Maintains Buy on FibroBiologics, Maintains $16 Price Target

Benzinga · 10/18 15:44
EF Hutton analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.